Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Interest & Investment Income: 2020-2023

Historic Interest & Investment Income for Pharming Group N.V (PHAR) over the last 2 years, with Dec 2023 value amounting to $799,000.

  • Pharming Group N.V's Interest & Investment Income was N/A to $2.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $799,000 for FY2023, which is N/A change from last year.
  • Pharming Group N.V's Interest & Investment Income amounted to $799,000 in FY2023, which was up 48.79% from $537,000 recorded in FY2020.
  • Pharming Group N.V's 5-year Interest & Investment Income high stood at $799,000 for FY2023, and its period low was $537,000 during FY2020.
  • Over the past 1 years, Pharming Group N.V's median Interest & Investment Income value was $799,000 (recorded in 2023), while the average stood at $799,000.